A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAA / polyaspartic acid

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAA  (>> Co-occurring Abbreviation)
Long Form:   polyaspartic acid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Electrochemical nucleic acid hybridization biosensor based on poly(L-Aspartic acid)-modified electrode for the detection of short oligonucleotide sequences related to hepatitis C virus 1a. HCV1a, MDB, PGE
2017 Evaluation of electrospun biomimetic substrate surface-decorated with nanohydroxyapatite precipitation for osteoblasts behavior. nHA, PHBV
2017 MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. BBB, BPN, BTB, CDDP-BPN, MRgFUS, PEG
2016 Poly(aspartic acid) (PAA) hydrolases and PAA biodegradation: current knowledge and impact on applications. tPAA
2014 In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex. apoB, CS, PGA
2011 Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy. PAHy, PGA, PHEA, PLL
2009 Cloning of poly(aspartic acid) (PAA) hydrolase-1 gene from Pedobacter sp. KP-2 and hydrolysis of thermally synthesized PAA by its gene product. tPAA
2009 Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model. ---
2008 Non-invasive optical characterization of biomaterial mineralization. LSS, SEM, TGA
10  2006 Partial poly(glutamic acid) <--> poly(aspartic acid) exchange in layer-by-layer polyelectrolyte films. Structural alterations in the three-component architectures. HSA, LbL, PGA, PLL
11  2006 Platelet separation from whole blood in an aqueous two-phase system with water-soluble polymers. PGA, PRP
12  2006 Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate. CM, NM, PLGA
13  2004 Formulation of a microparticle carrier for oral polyplex-based DNA vaccines. PEG, PEI, PLGA
14  2004 Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. DTT, PHPMA
15  2003 Biochemical and molecular characterization of poly(aspartic acid) hydrolase-2 from sphingomonas sp. KT-1. ---
16  2003 Genetic analysis and characterization of poly(aspartic acid) hydrolase-1 from Sphingomonas sp. KT-1. PHB
17  2002 Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency. PDL, pDNA, PLL, PLO
18  2001 Purification and characterization of poly(aspartic acid) hydrolase from Sphingomonas sp. KT-1. ---
19  2001 [Experimental observation of antagonism of polyaspartic acid against gentamicin-induced phospholipidosis in cochlea of guinea pig]. ABR, HPLC, PI, PIP
20  2001 [Experimental study on polyaspartic acid inhibition of gentamicin-induced generation of reactive oxygen species in guinea pig cochlea]. EPR, ROS
21  2001 [Safety and efficacy of LK565--a new polymer ultrasound contrast medium]. ---
22  2000 Microbial degradation of poly(aspartic acid) by two isolated strains of Pedobacter sp. and Sphingomonas sp. ---
23  1999 [Protective effect of poly DL-aspartic acid on ototoxicity of gentamicin]. GM
24  1997 Poly-l-aspartic acid protects cultured human proximal tubule cells against aminoglycoside-induced electrophysiological alterations. Rt
25  1995 Effects and interactions of gentamicin, polyaspartic acid and diuretics on urine calcium concentration. ---
26  1993 Characteristics of cadmium-induced nephrotoxicity in Syrian hamsters. Cd, NAG
27  1993 Effect of polyaspartic acid on CdCl2-induced nephrotoxicity in the rat. AAP, FENa, NAG, SD
28  1993 Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity. ---
29  1993 Use of poly-l-aspartic acid to inhibit aminoglycoside cochlear ototoxicity. ---
30  1992 Determinants of the in vitro interaction of polyaspartic acid and aminoglycoside antibiotics. ---
31  1992 Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity. ---
32  1992 Poly-L-aspartic acid does but triiodothyronine does not protect against gentamicin-induced cytotoxicity in the porcine kidney cell line LLC-PK1. ---
33  1991 Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. ---
34  1990 Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism. PC, PI
35  1989 Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. ---
36  1989 Polyaspartic acid protects against gentamicin nephrotoxicity in the rat. ---